Correspondingly, CIRP KO reduced the rise of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) induced by AP, which means alleviating damage of hepatic function (Fig. 5D, E). This evidence concerns the gene CIRBP and alkaline phosphatase measurement.